Can I Take L-Theanine with Adderall XR?

L-theanine, chemically gamma-glutamylethylamide, is an amino acid found mainly in Camellia sinensis (tea) and sold as an over-the-counter dietary supplement, not an FDA-approved drug. Adderall XR is the brand name for extended-release mixed amphetamine salts (a 3:1 ratio of dextroamphetamine to levoamphetamine), FDA-approved for ADHD and narcolepsy, delivered as a two-pulse capsule. Combining a stimulant with an amino-acid supplement raises a pharmacodynamic question (do their effects on the brain overlap or conflict) that is distinct from a pharmacokinetic question (does one change how the body handles the other). This page addresses both, and is honest about where the evidence runs out.

The direct answer

There is no known pharmacokinetic interaction between L-theanine and Adderall XR. Amphetamine clearance depends on CYP2D6 activity and on urinary pH, and L-theanine does neither: it is not a CYP2D6 substrate or inhibitor, and it does not meaningfully acidify or alkalinize urine. That distinguishes it from supplements such as high-dose vitamin C (which can acidify urine and speed amphetamine excretion) or St. John's wort (which induces CYP enzymes). The evidence anchor for this is the mechanism of action described in the current Adderall XR FDA prescribing information and the general pharmacology of L-theanine absorption, which relies on intestinal amino-acid transporters rather than the transporters or enzymes amphetamine uses.

How Adderall XR works and is cleared

Adderall XR raises synaptic dopamine and norepinephrine by promoting their release and blocking reuptake at their transporters. The extended-release capsule is built to release roughly half its dose immediately and the remainder several hours later. Amphetamine is metabolized in the liver, substantially through CYP2D6, and a meaningful fraction is excreted unchanged in urine. Because renal excretion is pH-dependent, more acidic urine speeds amphetamine clearance and more alkaline urine slows it. This is documented in current prescribing information and is the reason some drug interaction warnings exist for substances that shift urinary pH.

L-theanine does not participate in this pathway. It is absorbed through sodium-coupled amino-acid transporters in the small intestine, is not extensively protein-bound, and is cleared renally with a short half-life, without altering urine pH. That absence of overlap is the basis for the "no known pharmacokinetic interaction" conclusion.

What L-theanine plausibly does to the nervous system

L-theanine crosses the blood-brain barrier and has been associated with increased cortical alpha-wave activity, a pattern linked to relaxed alertness rather than sedation. Small trials have reported that it raises brain GABA and modestly affects dopamine and serotonin signaling, and acts as a partial antagonist at some glutamate receptor subtypes. These findings come mostly from small human studies and animal models; the exact magnitude of effect in humans, and how it generalizes across doses and products, is not settled and would need verification against the primary trial literature before treating any specific number as reliable.

Because L-theanine's dopamine and GABA effects are indirect and comparatively mild next to receptor-active drugs like benzodiazepines or gabapentin, opposing amphetamine's much larger dopamine surge at standard supplement doses is biologically plausible as a mild effect, but no clinical trial in stimulant users has measured whether it actually blunts stimulant efficacy.

The pharmacodynamic question: does it help with stimulant jitteriness?

Some people take L-theanine alongside a stimulant hoping it will ease the anxious, "wired" feeling that amphetamines can produce, without dulling focus. Several small randomized trials in general (non-ADHD, non-stimulant) populations have reported reduced subjective stress or anxiety measures with L-theanine doses in the 100 to 400 mg range. These trials support the idea that L-theanine has a genuine, non-sedating anxiolytic signal in some settings. They do not, however, include people taking prescription amphetamines, so the extrapolation to "reduces Adderall-related anxiety" is a plausible hypothesis carried over from a different population, not a demonstrated effect in stimulant users.

One published pediatric trial specifically studied L-theanine in boys with ADHD (roughly 400 mg daily for six weeks) and reported improved sleep measures without worsening clinician-rated ADHD symptoms. That is the closest available evidence to this page's exact question, and even it addressed sleep quality rather than daytime jitteriness or anxiety during stimulant treatment. Because the underlying citation could not be independently re-verified for this draft, treat the specific numbers as needing confirmation against the primary paper before quoting them as settled fact.

Caffeine complicates this picture further. L-theanine and caffeine have been studied together in cognitive and mood trials, generally with the finding that the combination modestly changes attention-task performance compared with caffeine alone. Anyone drinking caffeinated tea is already combining L-theanine and caffeine; adding a prescription stimulant on top of that pairing has not been studied as a three-way combination in a controlled trial.

Evidence-status interaction assessment

Dosing considerations

There is no FDA-approved dose for L-theanine because it is regulated as a dietary supplement, not a drug. Trials in the literature have generally used 100 to 400 mg per day, taken once or split into two doses. Because no pharmacokinetic conflict has been identified, there is no established medical requirement to separate L-theanine dosing in time from Adderall XR. Some people take both together to align timing; others take L-theanine in the evening to help with stimulant-related sleep disruption. Neither timing strategy has been tested head-to-head in stimulant users.

A cautious starting approach, absent individualized clinician guidance:

• Start with a low dose (for example 100 mg) rather than jumping to the highest studied amount
• Introduce it as a single new variable, not alongside other new supplements, so any effect can be attributed correctly
• Reassess after one to two weeks before increasing
• Treat 400 mg per day as the upper bound seen in published trials, not a target to reach automatically

This is general information, not an individualized dosing instruction. A prescriber or pharmacist familiar with your full medication list should confirm any specific plan.

Monitoring recommendations

Adding any supplement to a Schedule II stimulant regimen warrants structured tracking, independent of whether a pharmacokinetic interaction exists.

Discontinue L-theanine and contact your prescriber if you notice reduced Adderall efficacy, new daytime drowsiness, or any allergic reaction such as rash, swelling, or difficulty breathing. L-theanine is not associated with a withdrawal syndrome and can generally be stopped without a taper, though any medication or supplement change should still be discussed with your prescriber.

What guidelines and regulators say

No major ADHD guideline body (such as the American Academy of Pediatrics) has issued specific language on combining L-theanine with stimulant medication. General pediatric ADHD guidance encourages discussing any complementary or dietary supplement with the treatment team and monitoring for both efficacy and safety, which is consistent with the monitoring approach above, though it does not constitute specific endorsement or warning about this pairing.

L-theanine has Generally Recognized as Safe (GRAS) status for use as a food ingredient in the United States, a food-additive designation, not a statement about safety when combined with a specific prescription stimulant (FDA). The FDA does not systematically evaluate supplement-drug interactions with the same rigor it applies to drug-drug interactions, so the absence of an FDA warning should not be read as an endorsement.

Special populations

Children and adolescents. Adderall XR is FDA-approved for ADHD starting at age 6. The pediatric L-theanine trial referenced above studied roughly 400 mg daily in boys ages 8 to 12; there is no published data on L-theanine in children under 8, combined with a stimulant or otherwise. Any use in a child should go through the child's pediatrician.

Pregnancy and lactation. Adderall XR carries reproductive risk considerations on its label, and L-theanine lacks robust human gestational safety data. Neither should be used in pregnancy without an explicit discussion with the prescribing clinician or a maternal-fetal medicine specialist.

CYP2D6 poor metabolizers. A meaningful minority of people are CYP2D6 poor metabolizers and clear amphetamine more slowly, which can raise plasma levels at standard doses. Because L-theanine does not affect CYP2D6 activity, this genetic variation does not change the interaction profile between the two compounds, but it does raise the general importance of monitoring blood pressure and heart rate on any stimulant regimen.

Product quality matters more than most people expect

L-theanine supplements do not go through FDA premarket approval for content accuracy, and independent testing organizations have periodically found products that fall short of their labeled amount. Choosing a product with third-party verification (such as USP or NSF International certification) reduces the risk of getting less L-theanine than the label states. Some clinical trials specifically used a patented, pure L-isomer form of theanine; generic products may contain a racemic mix of L- and D-theanine, and the D-isomer is not well studied. If the goal is to approximate what was used in published research, a label that specifies pure L-theanine content is preferable to an unspecified blend.

Bottom line

If you are already taking L-theanine alongside Adderall XR and have not noticed reduced stimulant efficacy, excessive daytime sedation, or new cardiovascular symptoms, the available evidence does not indicate an urgent need to stop. It does indicate a need to tell your prescriber, since any supplement taken with a controlled substance should be documented in your medical record. Track resting heart rate and blood pressure at home for the first month, and use a consistent ADHD symptom scale at baseline and around four weeks to confirm your stimulant is still working as expected. Seek urgent care for chest pain, fainting, severe agitation, or signs of an allergic reaction rather than waiting for a routine follow-up.